Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

This study has been completed.
Sponsor:
Collaborator:
MedImmune LLC
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00689741
First received: May 30, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted